• 1
    Hosking SW, Ling TK, Chung SC, et al.Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 50810.
  • 2
    Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 1829.
  • 3
    Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. Br Med J 1997; 314: 14301.
  • 4
    Forman D. Should we go further and screen and treat? Eur J Gastroenterol Hepatol 1999; 11(Suppl. 2): S69S71.
  • 5
    Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348: 1504.
  • 6
    Sonnenberg A, Inadomi JM. Review article: medical decision models of Helicobacter pylori therapy to prevent gastric cancer. Aliment Pharmacol Ther 1998; 12 (Suppl. 1): 11121.
  • 7
    Moayyedi P, Feltbower RJ, Brown J, et al.The effect of population H. pylori screening and treatment on dyspepsia and quality of life in the community: results of a randomised controlled trial. Lancet 2000; 355: 16659.
  • 8
    Moayyedi P, Braunholtz D, Heminbrough E, et al.Do patients need to fast for a 13C-urea breath test? Eur J Gastroenterol Hepatol 1997; 9: 2757.
  • 9
    Mason JM, Moayyedi P, Young PJ, et al.Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group. Int J Technol Assess Health Care 1999; 15: 64960.
  • 10
    Knill-Jones R, Drummond M, Kohli H, Davies L. Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J 1990; 66: 63946.
  • 11
    Office of Population Censuses and Surveys. Mortality Statistics: Review of the Register General on Deaths by Cause, Sex and Age in England and Wales in 1993. London: HMSO, 1995.
  • 12
    Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl 1996; 220: 236.
  • 13
    Laine L. The long-term management of patients with bleeding ulcers: Helicobacter pylori eradication instead of maintenance antisecretory therapy. Gastrointest Endosc 1995; 41: 779.
  • 14
    Henriksson AE, Edman AC, Held M, Wadstrom T. Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol 1995; 7: 76971.
  • 15
    Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 14.
  • 16
    Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41: 57.
  • 17
    Wilcox MH, Dent TH, Hunter JO, et al.Accuracy of serology for the diagnosis of Helicobacter pylori infection — a comparison of eight kits. J Clin Pathol 1996; 49: 3736.
  • 18
    Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. Br Med J 1999; 318: 9048.
  • 19
    Tengs TO, Adams ME, Pliskin JS, et al.Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995; 15: 36990.
  • 20
    Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 1996; 38: 8225.
  • 21
    Uemura N, Mukai T, Okamoto S, et al.Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol, Biomarkers Prevention 1997; 6: 63942.
  • 22
    Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 1998; 316: 73641.
  • 23
    Wilhelmsen L, Ljungberg S, Wedel H, Werko L. A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis 1976; 29: 3319.
  • 24
    Chow WH, Blaser MJ, Blot WJ, et al.An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 58890.
  • 25
    Limburg PJ, Dawsey SM, Qiao YL, et al.Helicobacter pylori seropositivity and gastric cardia cancer: positive association in a prospective, nested case-cohort study from Linxian, China (Abstract). Gastroenterology 1999; 116: 13741374.
  • 26
    Moayyedi P, Forman D, Duffett S, et al.The rates of acquisition and disappearance of Helicobacter pylori in a UK adult population. Gut 1999; 45 (Suppl. V): A60A60(Abstract).
  • 27
    Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999; 13: 8516.
  • 28
    Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl 1996; 215: 4851.
  • 29
    Netten A, Dennett J, Knight J. Unit Costs of Health and Social Care 1998. University of Kent at Canterbury: Personal Social Services Research Unit (PSSRU), 1998.
  • 30
    British National Formulary Number 36 (September 1998). London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1998.
  • 31
    Hospital Episode Statistics. England: Financial Year 1994–95. Department of Health. London: HMSO, 1996.
  • 32
    Moayyedi P, Forman D, Braunholtz D, Crocombe W, Liptrott M, Axon ATR. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol 2000; 95: 144855.
    Direct Link:
  • 33
    Moayyedi P, Feltbower RG, Crocombe W, et al.The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat program. Aliment Pharmacol Ther 2000; 14: 71928.
  • 34
    Bodger K, Daly MJ, Heatley RV, Williams DR. Clinical economics review: gastroenterology. Aliment Pharmacol Ther 1996; 10: 5560.